Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Lung Cancer Screening, Version 1.2015 Featured Updates to the NCCN Guidelines JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Wood, D. E., Kazerooni, E., Baum, S. L., Dransfield, M. T., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., Leard, L. E., Leung, A. N., Makani, S. S., Massion, P. P., Meyers, B. F., Otterson, G. A., Peairs, K., Pipavath, S., Pratt-Pozo, C., Reddy, C., Reid, M. E., Rotter, A. J., Sachs, P. B., Schabath, M. B., Sequist, L. V., Tong, B. C., Travis, W. D., Yang, S. C., Gregory, K. M., Hughes, M. 2015; 13 (1): 23-34

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening provide recommendations for selecting individuals for lung cancer screening, and for evaluation and follow-up of nodules found during screening, and are intended to assist with clinical and shared decision-making. These NCCN Guidelines Insights focus on the major updates to the 2015 NCCN Guidelines for Lung Cancer Screening, which include a revision to the recommendation from category 2B to 2A for one of the high-risk groups eligible for lung cancer screening. For low-dose CT of the lung, the recommended slice width was revised in the table on "Low-Dose Computed Tomography Acquisition, Storage, Interpretation, and Nodule Reporting."

View details for Web of Science ID 000347793200007

View details for PubMedID 25583767